Data and analytics company GlobalData has weighed up the factors for consideration surrounding the prevention of thrombosis in managing COVID-19 patients. 6 August 2021
When the US regulator said in December it could not complete its review of a submission for heart med inclisiran, a potential blockbuster, it came as something 7 July 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.